As of 2025-10-20, the Relative Valuation of Zevra Therapeutics Inc (ZVRA) is 2.72 USD. This relative valuation is based on P/E multiples. With the latest stock price at 10.81 USD, the upside of Zevra Therapeutics Inc based on Relative Valuation is -74.8%.
The range of the Relative Valuation is 2.22 - 4.44 USD.
| Range | Selected | |
| Trailing P/E multiples | 47.1x - 90.0x | 55.1x |
| Forward P/E multiples | 51.3x - 94.2x | 60.4x |
| Fair Price | 2.22 - 4.44 | 2.72 |
| Upside | -79.5% - -58.9% | -74.8% |
| Date | P/E |
| 2025-10-14 | 222.73 |
| 2025-10-13 | 226.98 |
| 2025-10-10 | 233.78 |
| 2025-10-09 | 229.74 |
| 2025-10-08 | 225.92 |
| 2025-10-07 | 216.36 |
| 2025-10-06 | 226.13 |
| 2025-10-03 | 207.02 |
| 2025-10-02 | 197.68 |
| 2025-10-01 | 200.23 |
| 2025-09-30 | 201.93 |
| 2025-09-29 | 202.56 |
| 2025-09-26 | 207.45 |
| 2025-09-25 | 202.14 |
| 2025-09-24 | 190.04 |
| 2025-09-23 | 172.20 |
| 2025-09-22 | 168.80 |
| 2025-09-19 | 162.86 |
| 2025-09-18 | 168.59 |
| 2025-09-17 | 155.64 |
| 2025-09-16 | 154.15 |
| 2025-09-15 | 153.51 |
| 2025-09-12 | 164.56 |
| 2025-09-11 | 168.80 |
| 2025-09-10 | 169.44 |
| 2025-09-09 | 174.32 |
| 2025-09-08 | 176.87 |
| 2025-09-05 | 190.04 |
| 2025-09-04 | 189.61 |
| 2025-09-03 | 189.40 |
| 2025-09-02 | 193.22 |
| 2025-08-29 | 192.58 |
| 2025-08-28 | 197.47 |
| 2025-08-27 | 198.74 |
| 2025-08-26 | 199.80 |
| 2025-08-25 | 198.74 |
| 2025-08-22 | 200.44 |
| 2025-08-21 | 201.93 |
| 2025-08-20 | 197.04 |
| 2025-08-19 | 191.20 |
| 2025-08-18 | 195.34 |
| 2025-08-15 | 200.23 |
| 2025-08-14 | 188.97 |
| 2025-08-13 | 200.23 |
| 2025-08-12 | 249.70 |
| 2025-08-11 | 248.43 |
| 2025-08-08 | 255.22 |
| 2025-08-07 | 257.56 |
| 2025-08-06 | 243.75 |
| 2025-08-05 | 242.91 |